The endocannabinoidome in neuropsychiatry: Opportunities and potential risks

Morris, G, Walder, Ken, Kloiber, S, Amminger, P, Berk, Michael, Bortolasci, Chiara, Maes, M, Puri, BK and Carvalho, AF 2021, The endocannabinoidome in neuropsychiatry: Opportunities and potential risks, Pharmacological Research, vol. 170, pp. 1-24, doi: 10.1016/j.phrs.2021.105729.

Attached Files
Name Description MIMEType Size Downloads

Title The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Author(s) Morris, G
Walder, KenORCID iD for Walder, Ken
Kloiber, S
Amminger, P
Berk, MichaelORCID iD for Berk, Michael
Bortolasci, ChiaraORCID iD for Bortolasci, Chiara
Maes, M
Puri, BK
Carvalho, AF
Journal name Pharmacological Research
Volume number 170
Article ID 105729
Start page 1
End page 24
Total pages 24
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2021-08
ISSN 1043-6618
Keyword(s) Affective disorders
Bipolar disorder
Endocannabinoid receptors
Oxidative stress
Language eng
DOI 10.1016/j.phrs.2021.105729
Field of Research 110999 Neurosciences not elsewhere classified
1115 Pharmacology and Pharmaceutical Sciences
Socio Economic Objective 920410 Mental Health
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 1 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 25 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 29 Jul 2021, 18:45:08 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact